Literature DB >> 11807715

ADAMs (a disintegrin and metalloproteinase) messenger RNA expression in Helicobacter pylori-infected, normal, and neoplastic gastric mucosa.

Tetsuro Yoshimura1, Toshihiko Tomita, Michael F Dixon, Anthony T R Axon, Philip A Robinson, Jean E Crabtree.   

Abstract

Helicobacter pylori is a risk factor for gastric cancer, and bacterial-epithelial interactions may be critical in this association. Studies using complementary DNA arrays indicated that the ADAM (A disintegrin and metalloproteinase) genes in gastric epithelial cells are differentially expressed after bacterial-epithelial interactions. Reverse-transcription polymerase chain reaction analysis of gastric biopsy specimens from patients with and without H. pylori showed that infection was associated with increased expression of ADAM 10 and ADAM 17 (tumor necrosis factor-alpha-converting enzyme) in antral mucosa, but no increases in ADAM 15 and ADAM 20 were observed. Increased ADAM 10 transcripts were observed only in cagA-negative infections. High levels of ADAM 10, ADAM 17, and ADAM 20 transcripts were present in gastric carcinoma. H. pylori stimulated temporal changes in ADAM 10 and ADAM 17 transcripts in gastric epithelial cells. Chronic infection with H. pylori may result in persistent mucosal increases in members of the ADAMs family. ADAMs-mediated ectodomain shedding may have a role in gastric carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11807715     DOI: 10.1086/338191

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  32 in total

Review 1.  ADAM-17: the enzyme that does it all.

Authors:  Monika Gooz
Journal:  Crit Rev Biochem Mol Biol       Date:  2010-04       Impact factor: 8.250

2.  Analysis of Gene Expression Profile of AGS Cells Stimulated by Helicobacter pylori Adhesion.

Authors:  Nayoung Kim; Woong-Yang Park; Jung Mogg Kim; Young Soo Park; Dong Ho Lee; Ji Hyun Park; Joo Sung Kim; Hyun Chae Jung; In Sung Song
Journal:  Gut Liver       Date:  2007-06-30       Impact factor: 4.519

3.  Prognostic value of ADAM17 in human gastric cancer.

Authors:  Tie-cheng Zhang; Wei-guo Zhu; Ming-de Huang; Rui-hua Fan; Xiao-fei Chen
Journal:  Med Oncol       Date:  2011-12-03       Impact factor: 3.064

4.  ADAM17 mediates hypoxia-induced drug resistance in hepatocellular carcinoma cells through activation of EGFR/PI3K/Akt pathway.

Authors:  Xiang-Jun Wang; Chang-Wei Feng; Min Li
Journal:  Mol Cell Biochem       Date:  2013-04-28       Impact factor: 3.396

5.  Expression of a-disintegrin and metalloproteinase 10 correlates with grade of malignancy in human glioma.

Authors:  Min Qu; B O Qiu; Wende Xiong; Dong Chen; Anhua Wu
Journal:  Oncol Lett       Date:  2015-02-27       Impact factor: 2.967

6.  miR-448 suppressed gastric cancer proliferation and invasion by regulating ADAM10.

Authors:  Xuesong Wu; Haoran Tang; Guobin Liu; Hui Wang; Jie Shu; Feng Sun
Journal:  Tumour Biol       Date:  2016-02-08

Review 7.  Role of the tumor microenvironment in the pathogenesis of gastric carcinoma.

Authors:  Hye Won Chung; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2014-02-21       Impact factor: 5.742

8.  Gastric transcription profile of Helicobacter pylori infection in the rhesus macaque.

Authors:  Jennifer L Huff; Lori M Hansen; Jay V Solnick
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

9.  ADAM17 is overexpressed in non-small cell lung cancer and its expression correlates with poor patient survival.

Authors:  Shuang-Shuang Ni; Ji Zhang; Wei-Li Zhao; Xiao-Chun Dong; Jin-Lin Wang
Journal:  Tumour Biol       Date:  2013-03-09

10.  Sheddase activity of tumor necrosis factor-alpha converting enzyme is increased and prognostically valuable in head and neck cancer.

Authors:  Lisheng Ge; Dejan Baskic; Per Basse; Lazar Vujanovic; Sebnem Unlu; Toshie Yoneyama; Andrea Vujanovic; Jie Han; Dragic Bankovic; Miroslaw J Szczepanski; Jennifer L Hunt; Ronald B Herberman; Susanne M Gollin; Robert L Ferris; Theresa L Whiteside; Eugene N Myers; Nikola L Vujanovic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.